The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection
Abstract
Depression represents a major public health problem. It is estimated that 13-20% of the population has some depressive symptoms at any given time and about 5% of the population is assumed to suffer from major depression. Known pathological processes include ischemia, neoplasia, necrosis, apoptosis, infection, and inflammation. Of those, inflammation is the most compatible with the waxing and waning course of depression, and could explain the biology of this disorder that has a fluctuating course with severe episodes that can be followed by partial or complete remission. Over the years a body of evidence has been accumulated suggesting that major depression is associated with dysfunction of inflammatory mediators. Major depression commonly co-occurs with ischemic heart disease and decreased bone mineral density. Depressive symptoms are known to have a negative impact on cardiovascular prognosis, increasing the mortality rate of coronary artery disease. Several lines of evidence indicate that brain cytokines, principally interleukin-1beta (IL-1beta) and IL-1 receptor antagonist may have a role in the biology of major depression, and that they might additionally be involved in the pathophysiology and somatic consequences of depression as well as in the effects of antidepressant treatment. A particularly unique and novel aspect of the studies and views discussed here is their potential to lead to interventions which may reduce the morbidity and mortality risks for osteoporosis, c…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a growing recognition that immune system actions profoundly impact mood regulation (3–6)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [6]
Citations
Cites
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,593
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Hippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V. L., Gillis, S. A., Henney, C. S., Kronheim, S. R., Grabstein, K. H., et al. (1985) · Nature · doi:10.1038/315641a0 · Cited by 1,559
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504
Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W. (1984) · Science · doi:10.1126/science.6334362 · Cited by 1,485
Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987) · Science · doi:10.1126/science.2443979 · Cited by 1,151
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Hannum, C. H., Wilcox, C. J., Arend, W. P., Joslin, F. G., Dripps, D. J., Heimdal, P. L., Armes, L. G., Sommer, A., Eisenberg, S. P., & Thompson, R. C. (1990) · Nature · doi:10.1038/343336a0 · Cited by 1,122
Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E. L., Brewer, M. T., Hannum, C. H., & Thompson, R. C. (1990) · Nature · doi:10.1038/343341a0 · Cited by 1,084
cDNA Expression Cloning of the IL-1 Receptor, a Member of the Immunoglobulin Superfamily
Sims, J. E., March, C. J., Cosman, D. J., Widmer, M. B., MacDonald, H. R., McMahan, C. J., Grubin, C. E., Wignall, J. M., Jackson, J. L., Call, S. M., et al. (1988) · Science · doi:10.1126/science.2969618 · Cited by 877
Cited by
Sorted by citations
Items 201–300 of 378
Blood Transfusion in Clinical Practice
(2012) · InTech eBooks · doi:10.5772/1868 · Cited by 31
Chaiton, M., O’Loughlin, J., Karp, I., & Lambert, M. (2010) · International Journal of Behavioral Medicine · doi:10.1007/s12529-010-9078-9 · Cited by 29
van Belkum, S. M., Bosker, F. J., Kortekaas, R., Beersma, D. G. M., & Schoevers, R. A. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.07.006 · Cited by 29
Exercise as a treatment modality for depression: A narrative review
Al‐Qahtani, A. M., Shaikh, M. A. K., & Shaikh, I. A. (2018) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2018.05.004 · Cited by 32
Potential diagnostic markers for postpartum depression point out to altered immune signaling
Licinio, J. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.142 · Cited by 29
Self-citationdel Rey, A., Verdenhalven, M., Lörwald, A. C., Meyer, C., Hernangómez, M., Randolf, A., Roggero, E., König, A., Heverhagen, J. T., Guaza, C., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.174 · Cited by 27
The “depressive” face of osteoporosis and the “osteoporotic” face of depression
Aloumanis, K., & Mavroudis, K. (2013) · HORMONES · doi:10.1007/bf03401301 · Cited by 29
Misener, V. L., Schachar, R. J., Ickowicz, A., MALONE, M. A., Roberts, W., Tannock, R., Kennedy, J. L., Pathare, T., & Barr, C. L. (2004) · Neuropsychobiology · doi:10.1159/000079976 · Cited by 29
Inflammation and Depression: A Nervous Plea for Psychiatry to Not Become Immune to Interpretation
Konsman, J. P. (2019) · Pharmaceuticals · doi:10.3390/ph12010029 · Cited by 27
Tsai, S. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.10.051 · Cited by 27
Stress, immunity, cytokines and depression
Anisman, H. (2002) · Acta Neuropsychiatrica · doi:10.1034/j.1601-5215.2002.140601.x · Cited by 28
Association of time spent in outdoor light and genetic risk with the incidence of depression
Lin, J., Yang, H., Zhang, Y., Cao, Z., Li, D., Sun, L., Zhang, X., & Wang, Y. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02338-0 · Cited by 26
Barr, A. M., Song, C., Sawada, K., Young, C. E., Honer, W. G., & Phillips, A. G. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570200319x · Cited by 26
Rubinow, D. R., & Girdler, S. S. (2011) · Depression and Anxiety · doi:10.1002/da.20833 · Cited by 27
Age at onset of major depressive disorder predicts reductions in NK cell number and activity
Frank, M. G., Frank, J. L. W., Hendricks, S. E., Burke, W. J., & Johnson, D. R. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00395-0 · Cited by 26
Licinio, J., Alvarado, I., & Wong, M.-L. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001137 · Cited by 26
Self-citationIdentification of autoimmune gene signatures in autism
Jung, J.-Y., Kohane, I. S., & Wall, D. P. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.62 · Cited by 24
Proteomic analysis of rat hippocampus exposed to the antidepressant paroxetine
McHugh, P., Rogers, G., Glubb, D., Joyce, P., & Kennedy, M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109102786 · Cited by 25
Cizza, G., Mistry, S., Nguyen, V. T., Eskandari, F., Martinez, P. E., Torvik, S., Reynolds, J. C., Gold, P. W., Sinai, N. B., Csákó, G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040894 · Cited by 25
Interleukin-6 Genetic Polymorphism and Chinese Major Depression
Hong, C., Yu, Y. W. ‐., Chen, T., & Tsai, S. (2005) · Neuropsychobiology · doi:10.1159/000089003 · Cited by 25
Affective Disorders, Bone Metabolism, and Osteoporosis
Mezuk, B. R. (2008) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9025-y · Cited by 25
Lee, Y., Jung, J., Ali, Z., Khan, I. A., & Oh, S. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/798192 · Cited by 27
Tohmi, M., Tsuda, N., Zheng, Y., Mizuno, M., Sotoyama, H., Shibuya, M., Kawamura, M., Kakita, A., Takahashi, H., & Nawa, H. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.08.034 · Cited by 25
Jun, T., Pae, C., Chae, J., Bahk, W., Kim, K., & Han, H. J. (2002) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2002.00943.x · Cited by 26
Human Borna Disease Virus Infection
Planz, O., Bechter, K., & Schwemmle, M. (2014) · ASM Press eBooks · doi:10.1128/9781555817909.ch6 · Cited by 23
Zvolensky, M. J., Kauffman, B. Y., Garey, L., Viana, A. G., & Matoska, C. T. (2022) · Behaviour Research and Therapy · doi:10.1016/j.brat.2022.104141 · Cited by 27
Neuroimmune modulation by tryptophan derivatives in neurological and inflammatory disorders
Kondo, T., Okada, Y., Saika, S., Yamaguchi, N., Hatakeyama, S., & Maruyama, K. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151418 · Cited by 24
Proliferations of Scientific Medical Journals: A Burden or A Blessing
Garba, S. (2010) · Oman Medical Journal · doi:10.5001/omj.2010.100 · Cited by 23
Inserra, A., Choo, J. M., Lewis, M. D., Rogers, G. B., Wong, M., & Licinio, J. (2019) · Scientific Reports · doi:10.1038/s41598-018-38055-8 · Cited by 23
Self-citationPharmacogenomics of neuroimmune interactions in human psychiatric disorders
Licinio, J., Mastronardi, C., & Wong, M. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2007.038471 · Cited by 23
Self-citationPsychiatry and Cardiovascular Disease
Schulman, J. K., Muskin, P. R., & Shapiro, P. A. (2005) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.3.2.208 · Cited by 24
Laifenfeld, D., Karry, R., Grauer, E., Klein, E., & Ben‐Shachar, D. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300357 · Cited by 23
Stastny, J., Konstantinidis, A., Schwarz, M., Rosenthal, N. E., Vitouch, O., Kasper, S. F., & Neumeister, A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01453-1 · Cited by 23
Sadness Predicts Death in Older People
Cooper, J. K., Harris, Y., & McGready, J. (2002) · Journal of Aging and Health · doi:10.1177/089826402237181 · Cited by 23
Baxter, A. J., Page, A., & Whiteford, H. A. (2011) · Epidemiology Research International · doi:10.1155/2011/832945 · Cited by 21
In immune defense: redefining the role of the immune system in chronic disease
Rubinow, K. B., & Rubinow, D. R. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.1/drubinow · Cited by 22
Heiser, P., Dickhaus, B., Opper, C., Hemmeter, U., Remschmidt, H., Wesemann, W., Krieg, J.-C., & Schreiber, W. (2001) · The World Journal of Biological Psychiatry · doi:10.3109/15622970109027498 · Cited by 22
Clinical Research on Antipsychotics in Bipolar Disorder
CHOU, J. C.-Y., Solhkhah, R., & Serper, M. R. (2000) · Journal of Psychiatric Practice · doi:10.1097/00131746-200011000-00003 · Cited by 22
Tajfard, M., Ghayour‐Mobarhan, M., Rahimi, H. R., Mouhebati, M., Esmaily, H., Ferns, G. A., Latiff, L. A., Taghipour, A., Mokhber, N., & Aziz, A. F. A. (2014) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.14589 · Cited by 21
Nassar, A., Sharon-Granit, Y., & Azab, A. N. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.05.019 · Cited by 20
Brain and COVID-19 Crosstalk: Pathophysiological and Psychological Manifestations
Verma, K., Amitabh, Prasad, D. N., Kumar, B., & Kohli, E. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00446 · Cited by 23
Miu, D. K. Y., & Chan, C. K. (2010) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2010.00665.x · Cited by 21
Understanding Cytokines Part II: Implications for Nursing Research and Practice
Corwin, E. J. (2000) · Biological Research For Nursing · doi:10.1177/109980040000200105 · Cited by 20
Morphine: axon regeneration, neuroprotection, neurotoxicity, tolerance, and neuropathic pain.
Berrios, I., Castro, C., & Kuffler, D. P. (2008) · PubMed · Cited by 19
Coming of Age:Anti-Cytokine Therapies
Song, X. (2002) · Molecular Interventions · doi:10.1124/mi.2.1.36 · Cited by 19
Depressive Störungen bei körperlich Kranken
Arolt, V., & Rothermundt, M. (2003) · Der Nervenarzt · doi:10.1007/s00115-003-1629-8 · Cited by 40
Neurological Involvement in COVID-19 Among Non-Hospitalized Adolescents and Young Adults
Havdal, L. B., Berven, L. L., Selvakumar, J. P., Stiansen-Sonerud, T., Leegaard, T. M., Tjade, T., Zetterberg, H., Blennow, K., & Wyller, V. B. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.915712 · Cited by 19
Essential fatty acids in the treatment of dry eye syndrome: A myth or reality?
Al-Mahmood, A. M., & Al-Swailem, S. A. (2014) · Saudi Journal of Ophthalmology · doi:10.1016/j.sjopt.2014.06.004 · Cited by 18
Role of extended release quetiapine in the management of bipolar disorders
Jurdi, R. A., Sajatovic, M., & Dixit, L. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s4903 · Cited by 18
Serum omega-3 fatty acids are associated with ultimatum bargaining behavior
Emanuele, E., Brondino, N., Re, S., Bertona, M., & Geroldi, D. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.09.020 · Cited by 18
Huoxue-Tongluo-Lishui-Decoction is visual-protective against retinal ischemia-reperfusion injury
Han, L., Zhang, M., Yang, Z., Diao, K., Jia, X., Li, M., & Tian, G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109998 · Cited by 17
Dolati, K., Rakhshandeh, H., & Shafei, M. N. (2011) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 17
Inhibition of Microglial Nitric Oxide Production by Hydrocortisone and Glucocorticoid Precursors
Chang, J. Y., & Liu, L.-Z. (2000) · Neurochemical Research · doi:10.1023/a:1007511221666 · Cited by 17
Knight, J. M., Szabó, A., Arapi, I., Wu, R., Emmrich, A., Hackett, E., Sauber, G., Yim, S., Johnson, B. D., Hari, P., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00116-5 · Cited by 17
Serum Inflammatory Cytokines and Depression in Coronary Artery Disease
Tajfard, M., Latiff, L. A., Rahimi, H. R., Mouhebati, M., Esmaily, H., Taghipour, A., Mahdipour, E., Davari, H., Saghiri, Z., Hanachi, P., et al. (2014) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.17111 · Cited by 16
Lisboa, S. F. D. S., Issy, A. C., Biojone, C., Montezuma, K., Fattori, V., Del-Bel, E. A., Guimarães, F. S., Cunha, F. Q., Verri, W. A., Jr., & Joca, S. R. L. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.11.008 · Cited by 16
Leucocyte telomere length is no molecular marker of physical frailty in late-life depression
Arts, M. H. L., Collard, R. M., Comijs, H. C., de Jonge, L., Penninx, B. W. J. H., Naarding, P., Kok, R., & Voshaar, R. C. O. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.07.016 · Cited by 15
Zhao, J., Lao, L., Cui, W., & Rong, J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1610-5 · Cited by 15
Rubinow, D. R., & Girdler, S. S. (2011) · Depression and Anxiety · doi:10.1002/da.20810 · Cited by 16
Polymorphism of CTLA‐4 gene for major depression in the Korean population
Jun, T., Pae, C., Chae, J., Bahk, W., & Kim, K. (2001) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2001.00901.x · Cited by 16
Welch, M. G., & Ruggiero, D. A. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)71012-6 · Cited by 16
Sharma, A., Muresanu, D. F., Sahib, S., Tian, Z. R., Nozari, A., Lafuente, J. V., Buzoianu, A. D., Bryukhovetskiy, I., Manzhulo, I., Patnaik, R., et al. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.09.003 · Cited by 15
Thomas, J., Khanam, R., & Vohora, D. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.10.003 · Cited by 15
Heiser, P., Lanquillon, S., Krieg, J. C., & Vedder, H. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.07.003 · Cited by 15
Neuroprotective astroglial response to neural damage and its relevance to affective disorders
Miguel-Hidalgo, J. J. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00054 · Cited by 14
The keys to improving depression outcomes
Rizvi, S. J., & Kennedy, S. H. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.002 · Cited by 14
Deep, S. N., Baitharu, I., Sharma, A., Gurjar, A. K. S., Prasad, D. N., & Singh, S. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153371 · Cited by 15
RetractedNahar, Z., Monisha, S. T., Qusar, M. S., & Islam, M. R. (2023) · Health Science Reports · doi:10.1002/hsr2.1175 · Cited by 14
C‐reactive protein and depressed mood in a sub‐group of smokers during nicotine abstinence
Corwin, E. J., & Klein, L. C. (2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.487 · Cited by 14
Naz, S., Farooq, U., Khan, A., Khan, H. Z., Karim, N., Sarwar, R., Hussain, J., & Rauf, A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00469 · Cited by 13
Maternal alterations in the proteome of the medial prefrontal cortex in rat
Völgyi, K., Udvari, E. B., Szabó, É. R., Györffy, B. A., Hunyadi‐Gulyás, É., Medzihradszky, K. F., Juhász, G. D., Kékesi, K. A., & Dobolyi, Á. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.05.013 · Cited by 12
Ağaçayak, K. S., Güler, R., & Ilyasov, B. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s216822 · Cited by 13
Effect of Cognitive Behavioural Therapy (CBT) on Depressed Female University Students in Karachi
Zadeh, Z. F., & Lateef, M. (2012) · Procedia - Social and Behavioral Sciences · doi:10.1016/j.sbspro.2012.12.001 · Cited by 12
The role of quetiapine extended release in the treatment of bipolar depression
Cristancho, M. A., & Thase, M. E. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0067-9 · Cited by 12
La psiconeuroinmunología en el proceso salud enfermedad.
Klínger, J. C., Herrera, J. A., Díaz, M. L., Jhann, A. A., Ávila, G., & Tobar, C. (2005) · Colombia medica · doi:10.25100/cm.v36i.2.342 · Cited by 12
Jun, T., Pae, C., Chae, J., Bahk, W., Kim, K., Pyo, C., & Han, H. J. (2003) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2003.01076.x · Cited by 12
Milewski, K. P., Żurakowski, A., Pająk, J., Pajak-Zielinska, E., Liszka, Ł., Buszman, P. P., Bis, J., Dębiński, M., & Buszman, P. E. (2010) · PubMed · Cited by 11
Li, X., Peng, Z., Jiang, L., Zhang, P., Yang, P., Yuan, Z., & Cheng, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1124845 · Cited by 11
Mirshafa, S. A., Azadbakht, M., & Ahangar, N. (2013) · Europe PMC (PubMed Central) · Cited by 11
Vogel, J., Auinger, A., & Riedl, R. (2018) · Lecture notes in information systems and organisation · doi:10.1007/978-3-030-01087-4_31 · Cited by 11
Ji, T., Ye, W., Xiao, W., Dawson, G., Dong, Q., & Gwenin, C. D. (2024) · Talanta · doi:10.1016/j.talanta.2024.126776 · Cited by 10
Effects of olanzapine on LPS-induced inflammation in rat primary glia cells
Faour-Nmarne, C., & Azab, A. N. (2015) · Innate Immunity · doi:10.1177/1753425915613425 · Cited by 11
Effects of taurine on resting-state fMRI activity in spontaneously hypertensive rats
Chen, V. C., Hsu, T., Chen, L., Chou, H.-C., Weng, J., & Tzang, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181122 · Cited by 10
Fatigue in female patients with major depression: the effect of comorbid anxiety disorders.
Ferentinos, P. P., Kontaxakis, V. P., Havaki-Kontaxaki, B. J., Dikeos, D. G., Papadimitriou, G. N., & Lykouras, L. P. (2011) · PubMed · Cited by 10
Tsiouris, J. A., Chauhan, V. P. S., Sheikh, A. M., Chauhan, A., Malik, M. N., & Vaughan, M. R. (2004) · Canadian Journal of Zoology · doi:10.1139/z04-122 · Cited by 10
Arolt, V., Rothermundt, M., Peters, M. A., & Leonard, B. E. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001115 · Cited by 10
Licinio, J., Licinio, A. W., Busnello, J. V., Ribeiro, L., Gold, P. W., Bornstein, S. R., & Wong, M. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03034-9 · Cited by 9
Self-citationDepression bei körperlichen Erkrankungen
Arolt, V., & Rothermundt, M. (2004) · Steinkopff eBooks · doi:10.1007/978-3-662-12845-9_19 · Cited by 9
Considering depression as a consequence of activation of the inflammatory response system
Korf, J., Klein, H. C., Versijpt, J. J., den Boer, J. A., & Horst, G. J. T. (2002) · Acta Neuropsychiatrica · doi:10.1034/j.1601-5215.2002.140101.x · Cited by 9
Luo, C.-W., Chen, S., Chiang, C., Wu, W., Chen, C., Chen, W., & Kuan, Y. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116846 · Cited by 9
The Cytokines and Depression Hypothesis: An Evaluation
Dunn, A. J. (2008) · Neuroimmune biology · doi:10.1016/s1567-7443(07)10023-5 · Cited by 8
Stress-induced changes of interleukin-1beta within the limbic system in the rat.
Badowska‐Szalewska, E., Klejbor, I., Sidor-Kaczmarek, J., Cecot, T., Lietzau, G., Spodnik, J. H., & Moryś, J. (2009) · PubMed · Cited by 8
Perera, T. D., & Lisanby, S. H. (2000) · Journal of Psychiatric Practice · doi:10.1097/00131746-200011000-00004 · Cited by 7
Neuroimmune Mediators: Are Cytokines Mediators of Depression?
de Beaurepaire, R., Swiergiel, A. H., & Dunn, A. J. (2005) · Wiley eBooks · doi:10.1002/9783527619672.ch22 · Cited by 7
Anhedonia in Major Depressive Disorder: Exploration of a Predictive Clinical Phenotype
Rizvi, S. J. (2015) · TSpace (University of Toronto) · Cited by 6
Στεφανάτου, Α., Kouris, N. T., & Lekakis, J. P. (2010) · PubMed · Cited by 6
Advances in Causes and Treatment of Autism
XiaoLi, W. U., Jin, F., & Duan, Y. (2015) · Scientia Sinica Vitae · doi:10.1360/n052015-0108 · Cited by 5
Ware, W. R. (2010) · Cited by 6
Cytokines and Post Traumatic Stress Disorders
Baker, D. G., Geracioti, T. D., Kasckow, J., Zoumakis, E., & Chrousos, G. P. (2003) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4615-0323-1_14 · Cited by 6
Azarfarin, M., Shahla, M. M., Mohaddes, G., & Dadkhah, M. (2025) · Acta Neuropsychiatrica · doi:10.1017/neu.2024.39 · Cited by 5
Metadata
- Authors
- Licinio, J., & Wong, M.-L.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Licinio, J
- ORCID
- Venue
- Molecular Psychiatry
- Published
- 1999-07-01
- Volume
- 4
- Issue
- 4
- Pages
- 317-327
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2103997793
- Cited by
- 380
- References
- 88
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 9 · 2021: 6 · 2020: 13 · 2019: 6 · 2018: 9 · 2017: 13 · 2016: 12 · 2015: 14 · 2014: 16 · 2013: 11 · 2012: 17
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, IL-1β, interleukin-1 receptor antagonist, neuroinflammation, neuroprotection, neurotoxicity, antidepressant treatment, cardiovascular risk, bone mineral density, osteoporosis
- MeSH terms
- Animals, Brain, Depressive Disorder, Humans, Inflammation, Neurotoxins, Stress, Psychological, Cytokines, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review